REGMF
Price:
$10.9491
Market Cap:
$71.94B
RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. Its products in various stages of development include RC18, which is under phase III clinical trials for the treatment of neuromyelitis optica spectrum disorder and rheumatoid arthritis, and phase II clinical trials for the treatment of IgA nephritis, S...[Read more]
Industry
Biotechnology
IPO Date
2021-01-21
Stock Exchange
OTC
Ticker
REGMF
According to RemeGen Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 72.92B. This represents a change of 35.16% compared to the average of 53.95B of the last 4 quarters.
The mean historical Enterprise Value of RemeGen Co., Ltd. over the last ten years is 22.38B. The current 72.92B Enterprise Value has changed 32.48% with respect to the historical average. Over the past ten years (40 quarters), REGMF's Enterprise Value was at its highest in in the March 2026 quarter at 73.01B. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.
Average
22.38B
Median
18.18B
Minimum
857.73M
Maximum
43.73B
Discovering the peaks and valleys of RemeGen Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.21%
Maximum Annual Enterprise Value = 43.73B
Minimum Annual Increase = -45.90%
Minimum Annual Enterprise Value = 857.73M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 43.73B | 141.52% |
| 2024 | 18.11B | -45.90% |
| 2023 | 33.47B | -14.76% |
| 2022 | 39.27B | 115.12% |
| 2021 | 18.25B | 29.47% |
| 2020 | 14.10B | 25.24% |
| 2019 | 11.26B | 1.21% |
The current Enterprise Value of RemeGen Co., Ltd. (REGMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
31.77B
5-year avg
30.56B
10-year avg
22.38B
RemeGen Co., Ltd.’s Enterprise Value is greater than Abivax S.A. (7.97B), greater than 3SBio Inc. (40.09B), greater than Shanghai Junshi Biosciences Co., Ltd. (42.80B), greater than Zealand Pharma A/S (20.72B), less than Sinopharm Group Co. Ltd. (97.77B), less than Kyowa Kirin Co., Ltd. (1.06T), greater than Genscript Biotech Corporation (4.67B), greater than Ypsomed Holding AG (4.18B), less than MatsukiyoCocokara & Co. (852.73B), less than Sinopharm Group Co. Ltd. (97.77B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 7.97B | $9.17B | |
| 40.09B | $6.88B | |
| 42.80B | $4.34B | |
| 20.72B | $3.45B | |
| 97.77B | $7.45B | |
| 1.06T | $7.88B | |
| 4.67B | $3.77B | |
| 4.18B | $4.84B | |
| 852.73B | $7.23B | |
| 97.77B | $7.65B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RemeGen Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RemeGen Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is RemeGen Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for RemeGen Co., Ltd. (REGMF)?
What is the 3-year average Enterprise Value for RemeGen Co., Ltd. (REGMF)?
What is the 5-year average Enterprise Value for RemeGen Co., Ltd. (REGMF)?
How does the current Enterprise Value for RemeGen Co., Ltd. (REGMF) compare to its historical average?